Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.
Laryngoscope. 2021 May;131(5):E1653-E1661. doi: 10.1002/lary.29214. Epub 2020 Nov 2.
OBJECTIVES/HYPOTHESIS: Mal de débarquement syndrome (MDDS) is characterized by a persistent rocking sensation, as though on a boat. It may occur following exposure to passive motion (motion-triggered MDDS [MT-MDDS]), or spontaneously (spontaneous-onset MDDS [SO-MDDS]). This study investigated the characteristics of MDDS patients with vestibular migraine (MDDS-VM) to those without (MDDS-O). STUDY DESIGN: Retrospective review. METHODS: Retrospective, single-center study of 62 patients with MDDS. Clinical characteristics, Dizziness Handicap Inventory (DHI), Migraine Disability Assessment Score (MIDAS), job impact, and optimal treatment(s) were studied. RESULTS: There were 23 MDDS-O (19 women), and 39 MDDS-VM (35 women) patients. Comparisons between MDDS-VM and MDDS-O showed significant differences in age of onset (41 vs. 52 years, P = .005), interictal visually induced dizziness (89.7% vs. 30.4%, P < .001), interictal head motion-induced dizziness (87.2% vs. 47.8%, P = .001), other vestibular sensations (59% vs. 13%, P < .001), interictal aural symptoms (25.6% vs. 0%, P = .008), number of interictal symptoms (4.3 vs. 2.3, P < .001), total DHI score (54.9 vs. 38.1, P = .005), DHI-P (physical domain) score (16.1 vs. 10, P = .004), DHI-F (functional domain) score (20.9 vs. 15.7, P = .016 MIDAS (4.6 vs. 32, P = .002), and job resignations (23.2% vs. 5%, P = .016). On the other hand, between-group comparisons for MT-MDDS and SO-MDDS did not reveal any significant differences whatsoever. For optimal treatment, venlafaxine was the most used (27.3%) in all groups. For MDDS-VM, antiepileptic drugs and migraine preventive vitamins were also useful in relieving symptoms. CONCLUSIONS: MDDS-VM patients appear to be more disabled than MDDS-O, in terms of severity of dizziness, job impact, and number of symptoms, but have good potential for improvement, particularly with migraine prophylactic treatment. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E1653-E1661, 2021.
目的/假设:晕动病(MDDS)的特征是持续的摇晃感,就像在船上一样。它可能发生在被动运动暴露后(运动触发 MDDS [MT-MDDS]),也可能自发发生(自发发作 MDDS [SO-MDDS])。本研究旨在探讨伴有前庭性偏头痛的 MDDS 患者(MDDS-VM)与无偏头痛的 MDDS 患者(MDDS-O)的特征差异。 研究设计:回顾性研究。 方法:对 62 例 MDDS 患者进行回顾性单中心研究。研究了临床特征、眩晕障碍量表(DHI)、偏头痛残疾评估量表(MIDAS)、工作影响和最佳治疗(若有)。 结果:MDDS-O 组有 23 例(19 例女性),MDDS-VM 组有 39 例(35 例女性)。MDDS-VM 组与 MDDS-O 组相比,发病年龄(41 岁 vs. 52 岁,P =.005)、间歇期视觉诱发的眩晕(89.7% vs. 30.4%,P<.001)、间歇期头部运动诱发的眩晕(87.2% vs. 47.8%,P =.001)、其他前庭感觉(59% vs. 13%,P<.001)、间歇期耳症状(25.6% vs. 0%,P =.008)、间歇期症状数量(4.3 个 vs. 2.3 个,P<.001)、DHI 总评分(54.9 分 vs. 38.1 分,P =.005)、DHI-P(身体领域)评分(16.1 分 vs. 10 分,P =.004)、DHI-F(功能领域)评分(20.9 分 vs. 15.7 分,P =.016)、MIDAS(4.6 分 vs. 32 分,P =.002)和辞职率(23.2% vs. 5%,P =.016)差异均有统计学意义。另一方面,MT-MDDS 和 SO-MDDS 组之间的组间比较没有显示出任何显著差异。在所有组中,文拉法辛的使用最为广泛(27.3%)。对于 MDDS-VM,抗癫痫药物和偏头痛预防维生素也有助于缓解症状。 结论:MDDS-VM 患者在眩晕严重程度、工作影响和症状数量方面似乎比 MDDS-O 患者更易残疾,但有很大的改善潜力,特别是偏头痛预防治疗。 证据水平:3 级喉镜,131:E1653-E1661,2021。
Laryngoscope. 2021-5
Laryngoscope. 2017-7
Curr Pain Headache Rep. 2024-7
Audiol Neurootol. 2024
Front Neurol. 2018-5-7
Cephalalgia. 2013-5-14
Otol Neurotol Open. 2025-1-29
Curr Pain Headache Rep. 2024-7
Laryngoscope Investig Otolaryngol. 2023-7-6
J Neurol. 2023-12